Cells benefit living organisms

Genes create the future

Cell Valley Group was co-founded by American and Hong Kong Chinese scientists from top universities such as Harvard and Cornell.  Leveraging cutting-edge research expertise, the group has established three core centers and five wholly-owned subsidiaries in South and North China, operating over 10,000 square meters of GMP workshops and international standard laboratories. Its core technologies lead the industry, including the nation's first clinical-grade retroviral vector production line and internationally leading gene editing systems. As the first foreign-invested enterprise to benefit from the medical open pilot program, the group established the Shenzhen-Hong Kong Cell Valley, creating a dual-driven model of "healthcare + consumption." Shenzhen Cell Valley, serving as the production and R&D headquarters, provides full-process CRO/CDMO services, collaborating with over a hundred institutions to tackle critical industry challenges and empower industrial development.